Mesenchymal stem cells therapy is raved as being the champion of immune modulators. Can the promise be realized?
It has been estimated that 70 million adults suffer from arthritis in the US. While there are several types of arthritis, rheumatoid arthritis and osteoarthritis are the major conditions that lead to disability. The economic burden of arthritis is estimated to reach $100 billion by the year 2020.